Multiple sclerosis and Foetal growth restriction

Summary:

Foetal growth restriction is found among people with Multiple sclerosis, especially for people who are female, 30-39 old.

The study analyzes which people have Foetal growth restriction with Multiple sclerosis. It is created by eHealthMe based on reports of 77 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,089 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Foetal growth restriction?

Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy) is found to be associated with 368 drugs and 449 conditions by eHealthMe. Check the latest studies of Foetal growth restriction.



On Jul, 10, 2026

77 people who have Multiple Sclerosis and Foetal Growth Restriction are studied.

Would you have Foetal growth restriction when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Foetal Growth Restriction *:

  • female: 86.15 %
  • male: 13.85 %

Age of people who have Multiple Sclerosis and experienced Foetal Growth Restriction *:

  • 0-1: 17.5 %
  • 2-9: 2.5 %
  • 10-19: 5.0 %
  • 20-29: 25.0 %
  • 30-39: 32.5 %
  • 40-49: 10.0 %
  • 50-59: 5.0 %
  • 60+: 2.5 %

Common co-existing conditions for these people *:

  1. Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 3.90%
  2. Rickets (softening of bones): 2 people, 2.60%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 2.60%
  4. High Blood Pressure: 2 people, 2.60%
  5. Depression: 2 people, 2.60%
  6. Vaginal Discharge: 1 person, 1.30%
  7. Pustular Psoriasis (raised bumps on the skin that are filled with pus): 1 person, 1.30%
  8. Osteoporosis (bones weak and more likely to break): 1 person, 1.30%
  9. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 1.30%
  10. Hypersensitivity: 1 person, 1.30%

Common drugs taken by these people *:

  1. Tysabri: 24 people, 31.17%
  2. Avonex: 12 people, 15.58%
  3. Copaxone: 9 people, 11.69%
  4. Rebif: 8 people, 10.39%
  5. Tecfidera: 7 people, 9.09%
  6. Gilenya: 6 people, 7.79%
  7. Solu-Medrol: 4 people, 5.19%
  8. Extavia: 3 people, 3.90%
  9. Plegridy: 3 people, 3.90%
  10. Methotrexate: 2 people, 2.60%

Common symptoms for these people *:

  1. Maternal Exposure During Pregnancy (use of substance during pregnancy): 36 people, 46.75%
  2. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 19 people, 24.68%
  3. Abortion Spontaneous (naturally occurring miscarriage): 12 people, 15.58%
  4. Premature Baby: 5 people, 6.49%
  5. Foetal Death (death of foetus): 4 people, 5.19%
  6. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.19%
  7. Foetal Heart Rate Abnormal: 4 people, 5.19%
  8. Low Birth Weight Baby: 4 people, 5.19%
  9. Depression: 3 people, 3.90%
  10. Premature Delivery: 3 people, 3.90%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Foetal growth restriction?

- Check whether Foetal growth restriction is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Foetal growth restriction:

All the conditions that are associated with Foetal growth restriction:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Foetal growth restriction and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: